15 July 2019 - Last week, President Trump declared his administration would soon issue an executive order mandating a so-called "favoured nations" policy in which U.S. government (presumably, Medicare and Medicaid) payments for drugs would be capped at the lowest price paid by a developed country. 

Thus far, details on the proposed policy have been scant.

Perhaps this is a political ploy. It's election season after all. Polling shows healthcare costs, and drugs in particular, are a major concern for voters across the country. Moreover, drug manufacturers appear to be unpopular among constituents.

Maybe it's a bargaining position. The Trump Administration is known for usage of strident language ahead of negotiations. Here, perhaps it's a message being sent to the pharmaceutical industry that they must do something about high drug prices, or else.

Read Forbes article